Bai Lin, Sun Yuxi, Si Jiping, Ding Zijie, Zhang Xinxin, Zhang Yanli, Xia Yunlong, Liu Ying
Heart Failure and Structural Cardiology Ward, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
Front Cardiovasc Med. 2023 Sep 25;10:1265269. doi: 10.3389/fcvm.2023.1265269. eCollection 2023.
The benefits of rhythm control for atrial fibrillation (AF) in heart failure with preserved ejection fraction (HFpEF) have not been conclusively determined. We assessed the effects of rhythm control on left atrial (LA) structure remodeling and prognosis in patients with AF and HFpEF.
This was a retrospective, real-world, observational study involving patients diagnosed with AF and HFpEF. The cohort was divided into rhythm-control and rate-control groups depending on their treatment strategies. The primary outcomes were all-cause mortality, rehospitalization for any cause, HF-related rehospitalization, and stroke. Differences in follow-up LA structure parameters were also analyzed.
Compared to the rate-control group, patients in the rhythm-control group had a lower risk of HF-related rehospitalization even after adjusting for potential confounders (adjusted HR 0.605, 95% CI 0.413-0.887, = 0.010). Moreover, rhythm-control therapy led to marked reductions in LA echocardiographic indicators and a higher proportion of LA reverse remodeling (LARR).
Rhythm-control therapy reverses LA structure remodeling and is associated with improved clinical outcomes; therefore, it is an optimal treatment approach for AF in HFpEF patients.
射血分数保留的心力衰竭(HFpEF)患者中,节律控制对心房颤动(AF)的益处尚未得到最终确定。我们评估了节律控制对AF合并HFpEF患者左心房(LA)结构重塑和预后的影响。
这是一项回顾性、真实世界的观察性研究,纳入诊断为AF和HFpEF的患者。根据治疗策略将队列分为节律控制组和心率控制组。主要结局为全因死亡率、任何原因的再住院、HF相关再住院和卒中。还分析了随访期间LA结构参数的差异。
与心率控制组相比,即使在调整潜在混杂因素后,节律控制组患者HF相关再住院风险更低(调整后HR 0.605,95%CI 0.413 - 0.887,P = 0.010)。此外,节律控制治疗导致LA超声心动图指标显著降低,LA逆向重塑(LARR)比例更高。
节律控制治疗可逆转LA结构重塑,并与改善临床结局相关;因此,它是HFpEF患者AF的最佳治疗方法。